XILONIBSA
As listed in the register: XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE
2%/1,8 ml · solución inyectable
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Lidocaína + epinefrina
- Made by
- Laboratorios Inibsa S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Laboratorios Inibsa S.A. |
|---|---|
| Active substance | Lidocaína + epinefrina |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 2%/1,8 ml |
| Form | solución inyectable |
| Classification | N01BB52 · Pain, sleep, mood, epilepsy and the brain |
| Route | vía intramuscular |
| Marketed | Yes, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE |
| Nº Registro | 40858 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solución inyectable1 products
- 2%/1,8 ml
- solución para pulverización cutánea1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.